CD4+ T cell markers associated with Treatment Outcomes in Tuberculosis: A Sub-analysis of a Phase IIB Trial of Acetylsalicylic acid and Ibuprofen as Adjunctive Therapy ✅ Just Accepted https://bit.ly/4wyUwiO
CD4+ T cell markers associated with Treatment Outcomes in Tuberculosis: A Sub-analysis of a Phase IIB Trial of Acetylsalicylic acid and Ibuprofen as Adjunctive Therapy
Tuberculosis patients may benefit from host-directed therapy (HDT), but predictive biomarkers are needed. Mtb-specific polyfunctional and CD153+ CD4+ T cel
bit.ly